Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and Myocardial Infarction

atazanavir sulfate has been researched along with Myocardial Infarction in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Mejias, A; Peeples, ME; Ramilo, O; Teng, MN1
Boccara, F; Costagliola, D; Cotte, L; de Castro, N; Duval, X; Duvivier, C; Grabar, S; Katlama, C; Lang, S; Mary-Krause, M; Partisani, M; Potard, V; Raffi, F; Ronot-Bregigeon, S; Simon, A; Tattevin, P; Weiss, L; Zucman, D1
Siedner, MJ; Triant, VA1
Chan, WW; Li, M; Zucker, SD1
Bress, AP; Crook, J; LaFleur, J; Myers, J; Ritchings, C; Rosenblatt, L; Sax, PE1
Jiang, W; Li, D; Tian, J; Zhang, G; Zhang, X1
Becker, KJ; Budoff, M; Burkholder, GA; Chow, FC; Crane, HM; Delaney, JAC; Drozd, DR; Eron, JJ; Geng, E; Heckbert, SR; Ho, EL; Huffer, A; Hunt, PW; Kalani, R; Kim, HN; Kitahata, MM; Mathews, WC; Moore, RD; Nance, RM; Ritchings, C; Rosenblatt, L; Saag, MS; Tirschwell, DL; Whitney, BM; Wood, BR; Zunt, JR1
Dabis, F; De Wit, S; El-Sadr, W; Kirk, O; Law, MG; Lundgren, JD; Monforte, Ad; Phillips, AN; Pradier, C; Reiss, P; Ryom, L; Sabin, CA; Weber, R; Worm, SW1

Other Studies

8 other study(ies) available for atazanavir sulfate and Myocardial Infarction

ArticleYear
Live Attenuated Vaccine With a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    The Journal of infectious diseases, 2020, 02-03, Volume: 221, Issue:4

    Topics: Atazanavir Sulfate; Case-Control Studies; Child; Child, Preschool; Darunavir; Gene Deletion; HIV; HIV Infections; Humans; Myocardial Infarction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses

2020
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
    The Journal of infectious diseases, 2020, 02-03, Volume: 221, Issue:4

    Topics: Adult; Atazanavir Sulfate; Case-Control Studies; Cohort Studies; Darunavir; Databases, Factual; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Treatment Outcome

2020
Darunavir and Cardiovascular Risk: Evaluating the Data to Inform Clinical Care.
    The Journal of infectious diseases, 2020, 02-03, Volume: 221, Issue:4

    Topics: Atazanavir Sulfate; Cardiovascular Diseases; Case-Control Studies; Darunavir; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Myocardial Infarction; Risk Factors

2020
Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.
    Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19

    Topics: Atazanavir Sulfate; Bilirubin; Cardiovascular Diseases; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Ischemic Stroke; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Time Factors

2020
Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.
    AIDS (London, England), 2017, 09-24, Volume: 31, Issue:15

    Topics: Adult; Aged; Atazanavir Sulfate; Cohort Studies; Female; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Risk Assessment; Stroke; Treatment Outcome; United States; Veterans

2017
Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis.
    European journal of pharmacology, 2018, Jun-05, Volume: 828

    Topics: Administration, Oral; Animals; Atazanavir Sulfate; Cell Line; Cell Proliferation; Collagen; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart; Hypertrophy; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Time Factors

2018
Association Between Bilirubin, Atazanavir, and Cardiovascular Disease Events Among People Living With HIV Across the United States.
    Journal of acquired immune deficiency syndromes (1999), 2019, 08-15, Volume: 81, Issue:5

    Topics: Adult; Atazanavir Sulfate; Bilirubin; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Myocardial Infarction; United States

2019
Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events.
    AIDS (London, England), 2013, Jan-28, Volume: 27, Issue:3

    Topics: Adult; Aged; Atazanavir Sulfate; Australia; Comorbidity; Drug Therapy, Combination; Europe; Female; Follow-Up Studies; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Oligopeptides; Prospective Studies; Pyridines; Risk Factors; Ritonavir; Stroke; Time Factors; Treatment Outcome; United States; Viral Load

2013